3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 17.73

Change

-0.13 (-0.73)%

Market Cap

N/A

Volume

1.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.96 (-4.48%)

USD 163.38B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-1.46 (-1.93%)

USD 25.01B
2801:HK iShares Core MSCI China ETF

-0.74 (-3.34%)

USD 22.57B
2823:HK iShares FTSE A50 China

-0.13 (-0.92%)

USD 21.68B
83188:HK ChinaAMC CSI 300 Index ETF

-0.50 (-1.23%)

USD 13.48B
82822:HK CSOP FTSE China A50

-0.15 (-1.22%)

USD 9.92B
9067:HK iShares Hang Seng TECH ETF

-0.03 (-2.40%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.24 (-2.42%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

-0.04 (-0.54%)

USD 3.03B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.85% 56% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.85% 56% F 58% F
Trailing 12 Months  
Capital Gain 16.19% 67% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.19% 68% D+ 66% D+
Trailing 5 Years  
Capital Gain 44.15% 79% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.15% 79% B- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 9.92% 85% B 73% C
Dividend Return 11.05% 85% B 71% C-
Total Return 1.13% 36% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 12.83% 70% C- 89% A-
Risk Adjusted Return 86.14% 97% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.